Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kidney outcomes of coenzyme Q10 supplementation in patients with genetically confirmed CoQ10 nephropathy in Japan.

Clinical and experimental nephrology·2026
Same author

Response to the Letter to the Editor Regarding: "Predicting Postoperative Neurological Outcomes in Metastatic Spinal Tumor Surgery Using Machine Learning".

Spine·2026
Same author

Extent of intramedullary short tau inversion recovery signal change predicts traumatic cervical spinal cord injury outcomes in surgically treated older adults: a multicenter study in Japan.

Asian spine journal·2026
Same author

Tree-based and sparse logistic models for predicting one-month postoperative performance status after surgery for spinal metastases.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
Same author

The prevalence and etiology of macro-growth hormone (GH).

Clinical chemistry and laboratory medicine·2026
Same author

Proximal and distal junctional failures after a short-segment minimally invasive surgery combination that incorporates anterior column realignment (ACR) for adult spinal deformity.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026

Related Experiment Video

Updated: Jun 27, 2026

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
11:42

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

Published on: November 4, 2019

Human stem cell factor (SCF) is a heparin-binding cytokine.

Satoko Kishimoto1, Shingo Nakamura, Hidemi Hattori

  • 1Research Institute, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, Japan.

Journal of Biochemistry
|December 17, 2008
PubMed
Summary

Chemically modified heparins bind to human stem cell factor (SCF), requiring specific sulfate groups. Immobilized SCF also stimulates human erythroleukemia cell proliferation.

More Related Videos

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells
07:14

A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells

Published on: May 17, 2021

Related Experiment Videos

Last Updated: Jun 27, 2026

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
11:42

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

Published on: November 4, 2019

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells
07:14

A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells

Published on: May 17, 2021

Area of Science:

  • Biochemistry
  • Cell Biology
  • Biotechnology

Background:

  • Heparin and its derivatives are known for diverse biological activities.
  • Stem cell factor (SCF) is a crucial cytokine involved in hematopoiesis and cell survival.
  • Understanding the molecular interactions between heparin-based molecules and SCF is important for therapeutic development.

Purpose of the Study:

  • To investigate the binding affinities of chemically modified heparins to human stem cell factor (SCF).
  • To elucidate the structural requirements of heparin for SCF binding.
  • To assess the biological effect of SCF immobilized on microparticles.

Main Methods:

  • Utilized fragmin/protamine microparticles (F/P MPs) for heparin derivative immobilization.
  • Employed enzyme-linked immunosorbent assay (ELISA) to quantify SCF binding.
  • Tested inhibition of SCF binding using varying concentrations of heparin, fragmin, and NaCl.

Main Results:

  • High concentrations of heparin and fragmin inhibited SCF binding to F/P MPs.
  • SCF binding was also inhibited by high salt concentrations (≥0.55 M NaCl).
  • Pre-immobilized SCF significantly promoted the proliferation of a human erythroleukemia cell line.

Conclusions:

  • A high content of all three sulfate groups in heparin's repeating disaccharide units is essential for SCF interaction.
  • SCF immobilized on F/P MPs exhibits biological activity, stimulating erythroleukemia cell proliferation.
  • These findings provide insights into heparin-SCF interactions and potential biotechnological applications.